Application Nr Approved Date Route Status External Links
ANDA208453 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Abiraterone Acetate Tablets Are Indicated In Combination With Prednisone For The Treatment Of Patients With 1. Metastatic Castration-Resistant Prostate Cancer (Crpc). Abiraterone Acetate Tablets Are A Cyp17 Inhibitor Indicated In Combination With Prednisone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer (Crpc). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Abiraterone Acetate ABIRATERONE ACETATE ZINC5224164

Comments